Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Phone-Based dementia care could cut hospital visits and ease caregiver burden

NCT ID NCT05669365

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a program called the Care Ecosystem, which provides phone- and web-based support and care coordination for people with dementia and their caregivers. Over 1,200 participants from six health systems took part. The goal was to see if this approach improves quality of care, reduces emergency visits, and lowers caregiver depression in real-world settings.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Care Ecosystem (phone- and web-based caregiver support and care coordination)
What this could lead to
If successful, this could show that remote, team-based dementia care improves patient outcomes and reduces healthcare costs in real-world settings.
What could go wrong
This is an observational effectiveness study, not a controlled trial, so results may vary across health systems and may not prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,227 people

The number who actually took part.

Started

Jan 2023

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria, PWD participant 1. Age 18+ 2. Provision of verbal consent (or surrogate consent), documented in REDCap, and assent 3. Willingness to enroll in the Care Ecosystem program 4. Lives in the community (i.e., not in an assisted living, board \& care, skilled nursing or memory care facility) at the time of enrollment 5. Have a dementia diagnosis documented in the EHR 6. Has had a visit with the referring provider in the last 12 months 7. Has a caregiver with a primary level of responsibility for the patient who is eligible and willing to participate Inclusion Criteria, Caregiver participant 1. Age 18+ 2. Provision of verbal consent, documented in REDCap 3. Has a primary level of responsibility for the care of a PWD-participant who is enrolling in the study 4. Willingness to enroll in the Care Ecosystem program and complete surveys Exclusion Criteria, PWD participant 1. PWD-participants for whom a substantial amount of the patient's healthcare utilization records cannot be accessed for research purposes by the study team. (see Note) 2. Is currently, or was ever enrolled, in the Care Ecosystem program. 3. Medical documentation indicates that the patient's dementia is a non-progressive type (e.g., due to a head injury or stroke, and not expected to progress). Note: This exclusion criteria will be operationalized differently at each site based on variations in data access options for their patient population; these options will include EHR and Medicare. A small percentage of participants may be enrolled from underrepresented populations for whom a substantial amount of utilization records cannot be accessed with written approval from the study PI. All participants must be affiliated with one of the 6 participating health systems: Ochsner Health System Providence Health \& Services Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center HealthPartners Institute University of Colorado, Denver University of California, San Francisco

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dementia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • HealthPartners

    Saint Paul, Minnesota, 55130, United States

  • LA County Harbor-UCLA Medical Center

    Torrance, California, 90502, United States

  • Ochsner Medical Center

    New Orleans, Louisiana, 70121, United States

  • Providence Health

    Portland, Oregon, 97213, United States

  • University of California, San Francisco

    San Francisco, California, 94158, United States

  • University of Colorado Health

    Denver, Colorado, 80209, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.